Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 60,000 shares at $20.51 ($1.2M) on 2019-02-06, disclosed to the SEC on 2019-02-08.
Open-market sale of $1.2M ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.51 | 25,000 | $513K | 41.6% |
| 2 | $20.51 | 25,000 | $513K | 41.6% |
| 3 | $20.82 | 5,000 | $104K | 8.4% |
| 4 | $20.85 | 5,000 | $104K | 8.4% |
| Total | $20.56 avg | 60,000 | $1.2M | 100% |
| Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |
| MGEN | SELL | 2017-03-13 | $83K | — | Filing → |